Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)

Not Recruiting

Trial ID: NCT01913340

Purpose

Hypoxic-ischemic encephalopathy (HIE), a condition of reduced blood and oxygen flow to a baby's brain near the time of birth, may cause death or neurologic disability. Cooling therapy (hypothermia) provides some protection, but about half of affected infants still have a poor outcome. This clinical trial will determine if the drug erythropoietin, given with hypothermia, is safe to use as a treatment that may further reduce the risk of neurologic deficits after HIE.

Official Title

Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes Study

Eligibility


Inclusion Criteria:

   - Newborns ≥ 36 weeks gestation, < 23 hours of age at time of consent, must meet all 3
   Inclusion Criteria to be eligible for the study:

      1. Perinatal depression = at least one of the following: a) Apgar ≤5 at 10 min or b)
      required resuscitation (endotracheal or mask ventilation, or chest compressions)
      at 10 min or c) pH < 7.0 or base deficit ≥15 in cord, arterial, or venous blood
      obtained at <60 min of age;

      2. Moderate to severe encephalopathy = at least 3 of 6 modified Sarnat criteria
      present between 1-6 h of birth: a) reduced level of consciousness; b) decreased
      spontaneous activity; c) hypotonia; d) decreased suck; e) decreased Moro reflex;
      or f) respiratory distress including periodic breathing or apnea; and

      3. Hypothermia = passive or active cooling begun by 6 hours of age.

Exclusion Criteria:

   - Intrauterine growth restriction (BW <1800 g);

   - Major congenital malformation; suspected genetic syndrome, metabolic disorder or TORCH
   infection;

   - Head circumference < 2 SD for gestation;

   - Infant for whom withdrawal of supportive care is being considered; or

   - Anticipated inability to collect primary endpoint at 12 months of age.

Intervention(s):

drug: Erythropoietin

drug: Normal saline

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Krisa Van Meurs, MD
6507235711